Sublobar resection is equivalent to lobectomy for T1a non–small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis

Journal of Surgical Research

Volumn 200, Issue 2, 2016, Pages 683-689

  Razi, Syed S ^a   John, Mohan M ^a   Sainathan, Sandeep ^b   Stavropoulos, Christos ^a,c  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c LENOX HILL HOSPITAL   (United States)

Author keywords

Elderly patients; Lobectomy; Lung cancer; Wedge resection

Indexed keywords

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; FEMALE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LUNG LOBECTOMY; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEGMENTECTOMY; SUBLOBAR RESECTION; WEDGE RESECTION; AGE; CANCER REGISTRY; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; EVALUATION STUDY; FOLLOW UP; LUNG NEOPLASMS; LUNG RESECTION; MORTALITY; PATHOLOGY; PROCEDURES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PNEUMONECTOMY; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 85027928607     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.08.045     Document Type: Article

References (30)

1. Siegel, R., Ma, J., Zou, Z., et al. Cancer statistics, 2014. CA Cancer J Clin, 64, 2014, 9.
2. Monirul Islam, K.M., Shostrom, V., Kessinger, A., et al. Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis. Lung Cancer, 82, 2014, 90.
3. Darling, G.E., Allen, M.S., Decker, P.A., et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg, 141, 2011, 662.
4. Ginsberg, R.J., Rubinstein, L.V., Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg, 60, 1995, 615.
5. American Joint Committee on Cancer. Lung Cancer staging. 7th ed, 2009 Available at: https://cancerstaging.org/references-tools/quickreferences/Documents/LungMedium.pdf Accessed September 18, 2014.
6. Chamogeorgakis, T., Ieromonachos, C., Georgiannakis, E., et al. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?. Interact Cardiovasc Thorac Surg, 8, 2009, 364.
7. Nakamura, H., Kawasaki, N., Taguchi, M., et al. Survival following lobectomy vs. limited resection for stage I lung cancer: a meta-analysis. Br J Cancer, 92, 2005, 1033.
8. Keenan, R.J., Landreneau, R.J., Maley, R.H. Jr., et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg, 78, 2004, 228.
9. Okada, M., Koike, T., Higashiyama, M., et al. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg, 132, 2006, 769.
10. Kates, M., Swanson, S., Wisnivesky, J.P., Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data. Chest, 139, 2011, 491.
11. Wisnivesky, J.P., Yankelevitz, D., Henschke, C.I., Stage of lung cancer in relation to its size: part 2. Evidence. Chest, 127, 2005, 1136.
12. Okada, M., Nishio, W., Sakamoto, T., et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg, 129, 2005, 87.
13. Whitson, B.A., Groth, S.S., Andrade, R.S., et al. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thorac Surg, 92, 2011, 1943.
14. Mery, C.M., Pappas, A.N., Bueno, R., et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest, 128, 2005, 237.
15. Wisnivesky, J.P., Henschke, C.I., Swanson, S., et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg, 251, 2010, 550.
16. Cancer and Leukemia Group B (CALGB 140503). Comparison oF different types of surgery in treating patients with stage IA non-small cell lung Cancer. Available at: http://clinicaltrials.gov/ct2/show/NCT00499330?term=non+small+cell+lung+cancer+and+lobectomy&rank=4. Accessed May 11, 2015.
17. Nakamura, K., Saji, H., Nakajima, R., et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol, 40, 2010, 271.
18. Gajra, A., Newman, N., Gamble, G.P., et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol, 21, 2003, 1029.
19. Osarogiagbon, R.U., Yu, X., Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database. J Thorac Oncol, 7, 2012, 1798.
20. Osarogiagbon, R.U., Ogbata, O., Yu, X., Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann Thorac Surg, 97, 2014, 385.
21. Jonnalagadda, S., Smith, C., Mhango, G., et al. The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer. Chest, 140, 2011, 433.
22. Little, A.G., Rusch, V.W., Bonner, J.A., et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg, 80, 2005, 2051.
23. Kent, M., Landreneau, R., Mandrekar, S., et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg, 96, 2013, 1747.
24. Detterbeck, F., Puchalski, J., Rubinowitz, A., et al. Classification of the thoroughness of mediastinal staging of lung cancer. Chest, 137, 2010, 436.
25. Edwards, J.P., Datta, I., Hunt, J.D., et al. The impact of computed tomographic screening for lung cancer on the thoracic surgery workforce. Ann Thorac Surg, 98, 2014, 447.
26. Hiraki, T., Gobara, H., Iguchi, T., et al. Radiofrequency ablation for early-stage nonsmall cell lung cancer. Biomed Res Int, 2014, 2014, 152087.
27. Westover, K.D., Seco, J., Adams, J.A., et al. Proton SBRT for medically inoperable stage I NSCLC. J Thorac Oncol, 7, 2012, 1021.
28. Lanuti, M., Sharma, A., Willers, H., et al. Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence. Ann Thorac Surg, 93, 2012, 921.
29. Timmerman, R., Paulus, R., Galvin, J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA, 303, 2010, 1070.
30. Crabtree, T., Puri, V., Timmerman, R., et al. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg, 145, 2013, 692.